The Patent Finder

Ibsa Institut Biochimique S.A.

37 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

5
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 13 to 30, 2026 · next Dec 13
  • 1 fee due Feb 8, 2027
    The maintenance fee for Highly Stable Formulations of Thyroid Hormone in Soft Capsules (US 11,717,486) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 2 fees due Jul 21 to 23, 2027 · next Jul 21
  • 1 fee due Oct 19, 2027
    The maintenance fee for Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules (US 9,314,435) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Aqueous oral solutions of steroid hormones and hydroxypropyl-beta-cyclodextrin with optimised bioavailability (US 10,646,586) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,691,411Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,943,668Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,252,770Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,592,186Biotechnological production of chondroitin
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,066,858Pharmaceutical composition for the sublingual administration of progesterone, and method for its preparation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,657,798Anti-inflammatory analgesic adhesive patch for external use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,266,611Hybrid Cooperative Complexes of Hyaluronic Acid
In force
 · Medium confidence
In forceMedium confidence
US 9,314,435Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,675,270Chondroitin complexes for transcutaneous absorption
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,842,883Aqueous oral solutions of steroid hormones and hydroxypropyl-β-cyclodextrin with optimised bioavailability
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
Also on record, not counted in the 37: 1 lapsed for an unpaid fee · 7 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited